Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1998-02

AUTHORS

C. F. Deacon, L. B. Knudsen, K. Madsen, F. C. Wiberg, O. Jacobsen, J. J. Holst

ABSTRACT

Glucagon-like peptide 1 (GLP-1) has great potential in diabetes therapy due to its glucose-dependent stimulation of insulin secretion, but this is limited by its rapid degradation, primarily by dipeptidyl peptidase IV. Four analogues, N-terminally substituted with threonine, glycine, serine or alpha-aminoisobutyric acid, were synthesised and tested for metabolic stability. All were more resistant to dipeptidyl peptidase IV in porcine plasma in vitro, ranging from a t1/2 of 159 min (Gly8 analogue) to undetectable degradation after 6 h (Aib8 analogue; t1/2 for GLP-1 (7-36) amide, 28 min). During i. v. infusion in anaesthetised pigs, over 50% of each analogue remained undegraded compared to 22.7 % for GLP-1 (7-36) amide. In vivo, analogues had longer N-terminal t1/2 (intact peptides: means, 3.3-3.9 min) than GLP-1 (7-36) amide (0.9 min; p < 0.01), but these did not exceed the C-terminal t1/2 (intact plus metabolite: analogues, 3.5-4.4 min; GLP-1 (7-36) amide, 4.1 min). Analogues were assessed for receptor binding using a cell line expressing the cloned receptor, and for ability to stimulate insulin or inhibit glucagon secretion from the isolated perfused porcine pancreas. All bound to the receptor, but only the Aib8 and Gly8 analogues had similar affinities to GLP-1 (7-36) amide (IC50; Aib8=0.45 nmol/l; Gly8=2.8 nmol/l; GLP-1 (7-36) amide=0.78 nmol/l). All analogues were active in the isolated pancreas, with the potency order reflecting receptor affinities (Aib8 > Gly8 > Ser8 > Thr8). N-terminal modification of GLP-1 confers resistance to dipeptidyl peptidase IV degradation. Such analogues are biologically active and have prolonged metabolic stability in vivo, which, if associated with greater potency and duration of action, may help to realise the potential of GLP-1 in diabetes therapy. More... »

PAGES

271-278

Journal

TITLE

Diabetologia

ISSUE

3

VOLUME

41

Related Patents

  • Dpp-Iv Resistant Gip Hybrid Polypeptides With Selectable Properties
  • Glp-1 Derivatives And Transmicosal Absorption Preparations Thereof
  • Stabilized Pharmaceutical Formulations Of Insulin Aspart
  • Chronic Treatment Regimen Using Glucagon-Like Insulinotropic Peptides
  • Chronic Treatment Regimen Using Glucagon-Like Insulinotropic Peptides
  • Albumin-Binding Derivatives Of Therapeutic Peptides
  • Glucagon-Like Peptide-1 Analogs With Long Duration Of Action
  • Glucagon-Like Peptide-1 Analogs With Long Duration Of Action
  • Gip Analog And Hybrid Polypeptides With Selectable Properties
  • Peptide Derivatives Of Exendin-4
  • Gip Analog And Hybrid Polypeptides With Selectable Properties
  • Protracted Glp-1 Compounds
  • Glp-1 Pharmaceutical Compositions
  • Cyclic Peptide Analogues For Non-Invasive Imaging Of Pancreatic Beta-Cells
  • Pharmaceutical Composition Comprising A Glp-1 Agonist, An Insulin And Methionine
  • Use Of Ave0010 For The Treatment Of Diabetes Mellitus Type 2
  • Pharmaceutical Composition For Use In The Treatment Of A Neurodegenerative Disease
  • Glp-1 Pharmaceutical Compositions
  • Pharmaceutical Composition For Use In The Treatment Of A Neurodegenerative Disease
  • Method For Administering Insulinotropic Peptides
  • Modified Glp-1 Peptides With Increased Biological Potency
  • Chronic Treatment Regimen Using Glucagon-Like Insulinotropic Peptides
  • Modified Transferrin Fusion Proteins
  • Analogues Of Glp-1
  • Glp-1 Derivative And Preparation Thereof Absorbable Via Mucous Membrane
  • Exendin Variant Peptides
  • Stable Analogs Of Peptide And Polypeptide Therapeutics
  • Growth Hormones With Prolonged In-Vivo Efficacy
  • N-Terminal Modified Exendin-4
  • Glucagon-Like Peptide-1 Analogs
  • Glucagon-Like Peptide-1 Analogs
  • Glucagon-Like Peptide-1 Analogs With Long Duration Of Action
  • Acylated Glp-1 Compounds
  • Analogues Of Glp-1
  • Glucagon Analogues
  • Insulin Glargine/Lixisenatide Fixed Ratio Formulation
  • Pharmaceutical Composition Comprising A Glp-1-Agonist And Methionine
  • Growth Hormones With Prolonged In-Vivo Efficacy
  • Glp-1, Exendin-4, Peptide Analogs And Uses Thereof
  • Stable Growth Hormone Compounds Resistant To Proteolytic Degradation
  • Cyclic Peptide Analogues For Non-Invasive Imaging Of Pancreatic Beta-Cells
  • Glucagon-Like Peptide-1 Analogs
  • Albumin-Binding Derivatives Of Therapeutic Peptides
  • Protracted Glp-1 Compounds
  • Stabilized Pharmaceutical Formulations Of Insulin Analogues And/Or Insulin Derivatives
  • Analogues Of Glp-1
  • Peptide Conjugates Of Glp-1 Receptor Agonists And Gastrin And Their Use
  • Glucagon-Like Peptide-1 Analogs
  • Glp-1 Derivatives And Uses Thereof
  • Conjugated Proteins With Prolonged In Vivo Efficacy
  • Gip And Exendin Hybrid Polypeptides
  • Albumin-Binding Derivatives Of Therapeutic Peptides
  • Albumin-Binding Derivatives Of Therapeutic Peptides
  • Glp-1 Receptor Agonist Peptide Gastrin Conjugates
  • Analogues Of Glp-1
  • Protracted Exendin-4 Compounds
  • Analogues Of Glp-1
  • Fusion Protein Of An Exendin To Modified Transferrin
  • Protracted Exendin-4 Compounds
  • Stabilized Pharmaceutical Formulations Of Insulin Analogues And/Or Insulin Derivatives
  • Stable Growth Hormone Compounds Resistant To Proteolytic Degradation
  • Glp-1 Analogs And Uses Thereof
  • Peptide Conjugates Of Glp-1 Receptor Agonists And Gastrin And Their Use
  • Pharmaceutical Combination For Improving Glycemic Control As Add-On Therapy To Basal Insulin
  • Alpha/Beta-Polypeptide Analogs Of Glucagon-Like Peptide-1
  • Fusion Protein Of Exendin-4 To A Transferrin (Tf) Polypeptide
  • Chronic Treatment Regimen Using Glucagon-Like Insulinotropic Peptides
  • Pharmaceutical Combination For Use In Glycemic Control In Diabetes Type 2 Patients
  • Glp-1 Derivatives And Transmicosal Absorption Preparations Thereof
  • Glucagon-Like Peptide-1 Analogs
  • Protracted Glp-1 Compounds
  • Gip Analog And Hybrid Polypeptides With Selectable Properties
  • Glp-1, Exendin-4, Peptide Analogs And Uses Thereof
  • Acylated Glp-1 Compounds
  • Method Of Treating A Subject Suffering Stroke Comprising Administering Glucagon-Like Peptide-1 Analogs
  • Acylated Glp-1 Compounds
  • Analogues Of Glp-1
  • Stable Analogs Of Peptide And Polypeptide Therapeutics
  • Combination Of An Insulin And A Glp-1-Agonist
  • Pharmaceutical Composition Comprising A Glp-1 Agonist And Methionine
  • Glp-1 Analogs And Uses Thereof
  • Stable Analogs Of Peptide And Polypeptide Therapeutics
  • Stabilized Pharmaceutical Formulations Of Insulin Analogues And/Or Insulin Derivatives
  • Growth Hormones With Prolonged In-Vivo Efficacy
  • Oral Delivery Of Modified Transferrin Fusion Proteins
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s001250050903

    DOI

    http://dx.doi.org/10.1007/s001250050903

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1013633156

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/9541166


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cross Reactions", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dipeptidyl Peptidase 4", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Stability", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glucagon", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glucagon-Like Peptide 1", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glucagon-Like Peptide-1 Receptor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glucagon-Like Peptides", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "In Vitro Techniques", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Insulin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Insulin Secretion", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pancreas", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Peptide Fragments", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Perfusion", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Binding", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Precursors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Glucagon", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Swine", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "University of Copenhagen", 
              "id": "https://www.grid.ac/institutes/grid.5254.6", 
              "name": [
                "Department of Medical Physiology, The Panum Institute, University of Copenhagen, Denmark, DK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Deacon", 
            "givenName": "C. F.", 
            "id": "sg:person.01026605564.74", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026605564.74"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Novo Nordisk (Denmark)", 
              "id": "https://www.grid.ac/institutes/grid.425956.9", 
              "name": [
                "Novo Nordisk A/S, M\u00e5l\u00f8v, Denmark, DK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Knudsen", 
            "givenName": "L. B.", 
            "id": "sg:person.0671224337.40", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671224337.40"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Novo Nordisk (Denmark)", 
              "id": "https://www.grid.ac/institutes/grid.425956.9", 
              "name": [
                "Novo Nordisk A/S, M\u00e5l\u00f8v, Denmark, DK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Madsen", 
            "givenName": "K.", 
            "id": "sg:person.01224745375.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224745375.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Novo Nordisk (Denmark)", 
              "id": "https://www.grid.ac/institutes/grid.425956.9", 
              "name": [
                "Novo Nordisk A/S, M\u00e5l\u00f8v, Denmark, DK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wiberg", 
            "givenName": "F. C.", 
            "id": "sg:person.0730500720.11", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730500720.11"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Copenhagen", 
              "id": "https://www.grid.ac/institutes/grid.5254.6", 
              "name": [
                "Department of Medical Physiology, The Panum Institute, University of Copenhagen, Denmark, DK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jacobsen", 
            "givenName": "O.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Copenhagen", 
              "id": "https://www.grid.ac/institutes/grid.5254.6", 
              "name": [
                "Department of Medical Physiology, The Panum Institute, University of Copenhagen, Denmark, DK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Holst", 
            "givenName": "J. J.", 
            "id": "sg:person.0632007550.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632007550.38"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1016/0026-0495(94)90164-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000673528"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejm199205143262003", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002597029"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf03190278", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006004995", 
              "https://doi.org/10.1007/bf03190278"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf03190278", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006004995", 
              "https://doi.org/10.1007/bf03190278"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001250050664", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008139775", 
              "https://doi.org/10.1007/s001250050664"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s001250050664", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008139775", 
              "https://doi.org/10.1007/s001250050664"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1128/mcb.7.8.2745", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009211257"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(87)91194-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010255523"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(87)91194-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010255523"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0005-2795(71)90123-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020695941"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0005-2795(71)90123-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020695941"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0167-0115(84)90066-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024711783"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diab.42.11.1678", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025259697"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1042/bj1870337", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025891669"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1042/bj1870337", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025891669"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1074/jbc.271.38.23222", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028514054"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1046/j.1365-2362.1997.1490691.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030514396"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1046/j.1365-2362.1997.1490691.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030514396"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/361362a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031441956", 
              "https://doi.org/10.1038/361362a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1515/bchm3.1991.372.1.313", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043420739"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0167-4838(93)90256-q", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043831406"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0167-4838(93)90256-q", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043831406"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1432-1033.1993.tb17986.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045335243"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0014-2999(96)00795-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047097301"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0167-4838(84)90230-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049167410"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0167-4838(84)90230-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049167410"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1172/jci116186", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051772692"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1021/jm00059a014", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1055933900"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1210/endo.136.8.7628397", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064280347"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1210/jcem.80.3.7883856", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064319418"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diab.38.3.338", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070735825"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diab.40.11.1488", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070736378"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diab.42.9.1219", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070737139"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diab.44.9.1126", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070737650"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diab.45.11.1524", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070737725"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.15.2.270", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070745632"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.17.9.1039", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070746463"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.19.11.1200", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070746952"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.19.8.843", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070747210"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1998-02", 
        "datePublishedReg": "1998-02-01", 
        "description": "Glucagon-like peptide 1 (GLP-1) has great potential in diabetes therapy due to its glucose-dependent stimulation of insulin secretion, but this is limited by its rapid degradation, primarily by dipeptidyl peptidase IV. Four analogues, N-terminally substituted with threonine, glycine, serine or alpha-aminoisobutyric acid, were synthesised and tested for metabolic stability. All were more resistant to dipeptidyl peptidase IV in porcine plasma in vitro, ranging from a t1/2 of 159 min (Gly8 analogue) to undetectable degradation after 6 h (Aib8 analogue; t1/2 for GLP-1 (7-36) amide, 28 min). During i. v. infusion in anaesthetised pigs, over 50% of each analogue remained undegraded compared to 22.7 % for GLP-1 (7-36) amide. In vivo, analogues had longer N-terminal t1/2 (intact peptides: means, 3.3-3.9 min) than GLP-1 (7-36) amide (0.9 min; p < 0.01), but these did not exceed the C-terminal t1/2 (intact plus metabolite: analogues, 3.5-4.4 min; GLP-1 (7-36) amide, 4.1 min). Analogues were assessed for receptor binding using a cell line expressing the cloned receptor, and for ability to stimulate insulin or inhibit glucagon secretion from the isolated perfused porcine pancreas. All bound to the receptor, but only the Aib8 and Gly8 analogues had similar affinities to GLP-1 (7-36) amide (IC50; Aib8=0.45 nmol/l; Gly8=2.8 nmol/l; GLP-1 (7-36) amide=0.78 nmol/l). All analogues were active in the isolated pancreas, with the potency order reflecting receptor affinities (Aib8 > Gly8 > Ser8 > Thr8). N-terminal modification of GLP-1 confers resistance to dipeptidyl peptidase IV degradation. Such analogues are biologically active and have prolonged metabolic stability in vivo, which, if associated with greater potency and duration of action, may help to realise the potential of GLP-1 in diabetes therapy.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1007/s001250050903", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1001482", 
            "issn": [
              "0012-186X", 
              "1432-0428"
            ], 
            "name": "Diabetologia", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "41"
          }
        ], 
        "name": "Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity", 
        "pagination": "271-278", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "40f207bec24874f0e8640392b2ede25e0aa3170d5fb680ff40358fdf38da40e4"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "9541166"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "0006777"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s001250050903"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1013633156"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s001250050903", 
          "https://app.dimensions.ai/details/publication/pub.1013633156"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T09:30", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000346_0000000346/records_99803_00000000.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://link.springer.com/10.1007%2Fs001250050903"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s001250050903'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s001250050903'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s001250050903'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s001250050903'


     

    This table displays all metadata directly associated to this object as RDF triples.

    274 TRIPLES      21 PREDICATES      78 URIs      39 LITERALS      27 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s001250050903 schema:about N14aca83b1d17498cb70a0459705eec6b
    2 N37e8c265041247c6af4eef211c31c5d6
    3 N419bc90c9b3c4ba197f2071afbcde700
    4 N468598c4506c42b1930e89ca80e141a1
    5 N4a305e491aae4c6a9f1a04c6babd0333
    6 N4f4c7ab19f0944378d8251093c16eb65
    7 N53c05f7bdb0c4341927bcec04c139ccb
    8 N5c57daaadc094a77a589fa8a962bf9e9
    9 N659fbacf9be94472a84e69bfaa8c2f74
    10 N6b7e9c5d1c2c4171bd0d705d298928b5
    11 N8820db7e78ef441ba5845e7c972b8ec2
    12 Na9addaed37214b0ab19185dbb816a682
    13 Nb37703345aa14297ab829b06da168c74
    14 Nb9286d7ac9284e5fad6175b95065a249
    15 Nc2d7682b5bdd4896afa95dac339564eb
    16 Nd1067756bf1049f9a805607d16861047
    17 Ne0344894f68c42338c5bdb4cc9e77dfd
    18 Nfaa4f1e3be1947a8b20bb7425688a86e
    19 anzsrc-for:11
    20 anzsrc-for:1103
    21 schema:author N9c5b32515e434b848298542af8c5249c
    22 schema:citation sg:pub.10.1007/bf03190278
    23 sg:pub.10.1007/s001250050664
    24 sg:pub.10.1038/361362a0
    25 https://doi.org/10.1016/0005-2795(71)90123-1
    26 https://doi.org/10.1016/0026-0495(94)90164-3
    27 https://doi.org/10.1016/0167-0115(84)90066-1
    28 https://doi.org/10.1016/0167-4838(84)90230-9
    29 https://doi.org/10.1016/0167-4838(93)90256-q
    30 https://doi.org/10.1016/s0014-2999(96)00795-9
    31 https://doi.org/10.1016/s0140-6736(87)91194-9
    32 https://doi.org/10.1021/jm00059a014
    33 https://doi.org/10.1042/bj1870337
    34 https://doi.org/10.1046/j.1365-2362.1997.1490691.x
    35 https://doi.org/10.1056/nejm199205143262003
    36 https://doi.org/10.1074/jbc.271.38.23222
    37 https://doi.org/10.1111/j.1432-1033.1993.tb17986.x
    38 https://doi.org/10.1128/mcb.7.8.2745
    39 https://doi.org/10.1172/jci116186
    40 https://doi.org/10.1210/endo.136.8.7628397
    41 https://doi.org/10.1210/jcem.80.3.7883856
    42 https://doi.org/10.1515/bchm3.1991.372.1.313
    43 https://doi.org/10.2337/diab.38.3.338
    44 https://doi.org/10.2337/diab.40.11.1488
    45 https://doi.org/10.2337/diab.42.11.1678
    46 https://doi.org/10.2337/diab.42.9.1219
    47 https://doi.org/10.2337/diab.44.9.1126
    48 https://doi.org/10.2337/diab.45.11.1524
    49 https://doi.org/10.2337/diacare.15.2.270
    50 https://doi.org/10.2337/diacare.17.9.1039
    51 https://doi.org/10.2337/diacare.19.11.1200
    52 https://doi.org/10.2337/diacare.19.8.843
    53 schema:datePublished 1998-02
    54 schema:datePublishedReg 1998-02-01
    55 schema:description Glucagon-like peptide 1 (GLP-1) has great potential in diabetes therapy due to its glucose-dependent stimulation of insulin secretion, but this is limited by its rapid degradation, primarily by dipeptidyl peptidase IV. Four analogues, N-terminally substituted with threonine, glycine, serine or alpha-aminoisobutyric acid, were synthesised and tested for metabolic stability. All were more resistant to dipeptidyl peptidase IV in porcine plasma in vitro, ranging from a t1/2 of 159 min (Gly8 analogue) to undetectable degradation after 6 h (Aib8 analogue; t1/2 for GLP-1 (7-36) amide, 28 min). During i. v. infusion in anaesthetised pigs, over 50% of each analogue remained undegraded compared to 22.7 % for GLP-1 (7-36) amide. In vivo, analogues had longer N-terminal t1/2 (intact peptides: means, 3.3-3.9 min) than GLP-1 (7-36) amide (0.9 min; p < 0.01), but these did not exceed the C-terminal t1/2 (intact plus metabolite: analogues, 3.5-4.4 min; GLP-1 (7-36) amide, 4.1 min). Analogues were assessed for receptor binding using a cell line expressing the cloned receptor, and for ability to stimulate insulin or inhibit glucagon secretion from the isolated perfused porcine pancreas. All bound to the receptor, but only the Aib8 and Gly8 analogues had similar affinities to GLP-1 (7-36) amide (IC50; Aib8=0.45 nmol/l; Gly8=2.8 nmol/l; GLP-1 (7-36) amide=0.78 nmol/l). All analogues were active in the isolated pancreas, with the potency order reflecting receptor affinities (Aib8 > Gly8 > Ser8 > Thr8). N-terminal modification of GLP-1 confers resistance to dipeptidyl peptidase IV degradation. Such analogues are biologically active and have prolonged metabolic stability in vivo, which, if associated with greater potency and duration of action, may help to realise the potential of GLP-1 in diabetes therapy.
    56 schema:genre research_article
    57 schema:inLanguage en
    58 schema:isAccessibleForFree true
    59 schema:isPartOf N8af87640349049269000fc2d12c0c196
    60 Na196ed5e3ef6427eabbcda8d0015f5d9
    61 sg:journal.1001482
    62 schema:name Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity
    63 schema:pagination 271-278
    64 schema:productId N3ca72cf9f2524084b14a8ea0e2676d20
    65 N9315981198ed4449bb7dc6090470e03e
    66 Na983c17a43634eeba29feb019d2f8fb4
    67 Nf4c38188d2ca4bdcaf34379ec5e8f2ab
    68 Nf5143b95e0cd4cb8b50593f8f2814d45
    69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013633156
    70 https://doi.org/10.1007/s001250050903
    71 schema:sdDatePublished 2019-04-11T09:30
    72 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    73 schema:sdPublisher Na0d639a1cde94a82be47eec8c8ea03ea
    74 schema:url https://link.springer.com/10.1007%2Fs001250050903
    75 sgo:license sg:explorer/license/
    76 sgo:sdDataset articles
    77 rdf:type schema:ScholarlyArticle
    78 N14aca83b1d17498cb70a0459705eec6b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    79 schema:name Animals
    80 rdf:type schema:DefinedTerm
    81 N37e8c265041247c6af4eef211c31c5d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    82 schema:name Cross Reactions
    83 rdf:type schema:DefinedTerm
    84 N3ca72cf9f2524084b14a8ea0e2676d20 schema:name pubmed_id
    85 schema:value 9541166
    86 rdf:type schema:PropertyValue
    87 N419bc90c9b3c4ba197f2071afbcde700 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    88 schema:name In Vitro Techniques
    89 rdf:type schema:DefinedTerm
    90 N468598c4506c42b1930e89ca80e141a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    91 schema:name Perfusion
    92 rdf:type schema:DefinedTerm
    93 N4a305e491aae4c6a9f1a04c6babd0333 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    94 schema:name Protein Precursors
    95 rdf:type schema:DefinedTerm
    96 N4f4c7ab19f0944378d8251093c16eb65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    97 schema:name Glucagon-Like Peptide-1 Receptor
    98 rdf:type schema:DefinedTerm
    99 N53c05f7bdb0c4341927bcec04c139ccb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    100 schema:name Insulin Secretion
    101 rdf:type schema:DefinedTerm
    102 N5c57daaadc094a77a589fa8a962bf9e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    103 schema:name Insulin
    104 rdf:type schema:DefinedTerm
    105 N5f26bd4c85dc4a1cbd79f4be5309063c rdf:first sg:person.0632007550.38
    106 rdf:rest rdf:nil
    107 N659fbacf9be94472a84e69bfaa8c2f74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    108 schema:name Glucagon-Like Peptide 1
    109 rdf:type schema:DefinedTerm
    110 N6b7e9c5d1c2c4171bd0d705d298928b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    111 schema:name Dipeptidyl Peptidase 4
    112 rdf:type schema:DefinedTerm
    113 N792445d8b4d0485fbea49fa913f4935b rdf:first sg:person.01224745375.19
    114 rdf:rest Ne252ed181d894151a62c29a627b3daf1
    115 N8820db7e78ef441ba5845e7c972b8ec2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Receptors, Glucagon
    117 rdf:type schema:DefinedTerm
    118 N8af87640349049269000fc2d12c0c196 schema:issueNumber 3
    119 rdf:type schema:PublicationIssue
    120 N9315981198ed4449bb7dc6090470e03e schema:name nlm_unique_id
    121 schema:value 0006777
    122 rdf:type schema:PropertyValue
    123 N9c5b32515e434b848298542af8c5249c rdf:first sg:person.01026605564.74
    124 rdf:rest Nbdb601816bb34d2aacdec75cfdbb9307
    125 Na0d639a1cde94a82be47eec8c8ea03ea schema:name Springer Nature - SN SciGraph project
    126 rdf:type schema:Organization
    127 Na196ed5e3ef6427eabbcda8d0015f5d9 schema:volumeNumber 41
    128 rdf:type schema:PublicationVolume
    129 Na983c17a43634eeba29feb019d2f8fb4 schema:name doi
    130 schema:value 10.1007/s001250050903
    131 rdf:type schema:PropertyValue
    132 Na9addaed37214b0ab19185dbb816a682 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    133 schema:name Swine
    134 rdf:type schema:DefinedTerm
    135 Nb37703345aa14297ab829b06da168c74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    136 schema:name Drug Stability
    137 rdf:type schema:DefinedTerm
    138 Nb4b7ffcb0205449dbc66d62c14eb77ad rdf:first Nd941b0e04f6f4ddd996e5b9837c36426
    139 rdf:rest N5f26bd4c85dc4a1cbd79f4be5309063c
    140 Nb9286d7ac9284e5fad6175b95065a249 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Glucagon-Like Peptides
    142 rdf:type schema:DefinedTerm
    143 Nbdb601816bb34d2aacdec75cfdbb9307 rdf:first sg:person.0671224337.40
    144 rdf:rest N792445d8b4d0485fbea49fa913f4935b
    145 Nc2d7682b5bdd4896afa95dac339564eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    146 schema:name Glucagon
    147 rdf:type schema:DefinedTerm
    148 Nd1067756bf1049f9a805607d16861047 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Protein Binding
    150 rdf:type schema:DefinedTerm
    151 Nd941b0e04f6f4ddd996e5b9837c36426 schema:affiliation https://www.grid.ac/institutes/grid.5254.6
    152 schema:familyName Jacobsen
    153 schema:givenName O.
    154 rdf:type schema:Person
    155 Ne0344894f68c42338c5bdb4cc9e77dfd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    156 schema:name Pancreas
    157 rdf:type schema:DefinedTerm
    158 Ne252ed181d894151a62c29a627b3daf1 rdf:first sg:person.0730500720.11
    159 rdf:rest Nb4b7ffcb0205449dbc66d62c14eb77ad
    160 Nf4c38188d2ca4bdcaf34379ec5e8f2ab schema:name dimensions_id
    161 schema:value pub.1013633156
    162 rdf:type schema:PropertyValue
    163 Nf5143b95e0cd4cb8b50593f8f2814d45 schema:name readcube_id
    164 schema:value 40f207bec24874f0e8640392b2ede25e0aa3170d5fb680ff40358fdf38da40e4
    165 rdf:type schema:PropertyValue
    166 Nfaa4f1e3be1947a8b20bb7425688a86e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    167 schema:name Peptide Fragments
    168 rdf:type schema:DefinedTerm
    169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    170 schema:name Medical and Health Sciences
    171 rdf:type schema:DefinedTerm
    172 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    173 schema:name Clinical Sciences
    174 rdf:type schema:DefinedTerm
    175 sg:journal.1001482 schema:issn 0012-186X
    176 1432-0428
    177 schema:name Diabetologia
    178 rdf:type schema:Periodical
    179 sg:person.01026605564.74 schema:affiliation https://www.grid.ac/institutes/grid.5254.6
    180 schema:familyName Deacon
    181 schema:givenName C. F.
    182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026605564.74
    183 rdf:type schema:Person
    184 sg:person.01224745375.19 schema:affiliation https://www.grid.ac/institutes/grid.425956.9
    185 schema:familyName Madsen
    186 schema:givenName K.
    187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224745375.19
    188 rdf:type schema:Person
    189 sg:person.0632007550.38 schema:affiliation https://www.grid.ac/institutes/grid.5254.6
    190 schema:familyName Holst
    191 schema:givenName J. J.
    192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632007550.38
    193 rdf:type schema:Person
    194 sg:person.0671224337.40 schema:affiliation https://www.grid.ac/institutes/grid.425956.9
    195 schema:familyName Knudsen
    196 schema:givenName L. B.
    197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0671224337.40
    198 rdf:type schema:Person
    199 sg:person.0730500720.11 schema:affiliation https://www.grid.ac/institutes/grid.425956.9
    200 schema:familyName Wiberg
    201 schema:givenName F. C.
    202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730500720.11
    203 rdf:type schema:Person
    204 sg:pub.10.1007/bf03190278 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006004995
    205 https://doi.org/10.1007/bf03190278
    206 rdf:type schema:CreativeWork
    207 sg:pub.10.1007/s001250050664 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008139775
    208 https://doi.org/10.1007/s001250050664
    209 rdf:type schema:CreativeWork
    210 sg:pub.10.1038/361362a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031441956
    211 https://doi.org/10.1038/361362a0
    212 rdf:type schema:CreativeWork
    213 https://doi.org/10.1016/0005-2795(71)90123-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020695941
    214 rdf:type schema:CreativeWork
    215 https://doi.org/10.1016/0026-0495(94)90164-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000673528
    216 rdf:type schema:CreativeWork
    217 https://doi.org/10.1016/0167-0115(84)90066-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024711783
    218 rdf:type schema:CreativeWork
    219 https://doi.org/10.1016/0167-4838(84)90230-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049167410
    220 rdf:type schema:CreativeWork
    221 https://doi.org/10.1016/0167-4838(93)90256-q schema:sameAs https://app.dimensions.ai/details/publication/pub.1043831406
    222 rdf:type schema:CreativeWork
    223 https://doi.org/10.1016/s0014-2999(96)00795-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047097301
    224 rdf:type schema:CreativeWork
    225 https://doi.org/10.1016/s0140-6736(87)91194-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010255523
    226 rdf:type schema:CreativeWork
    227 https://doi.org/10.1021/jm00059a014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055933900
    228 rdf:type schema:CreativeWork
    229 https://doi.org/10.1042/bj1870337 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025891669
    230 rdf:type schema:CreativeWork
    231 https://doi.org/10.1046/j.1365-2362.1997.1490691.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1030514396
    232 rdf:type schema:CreativeWork
    233 https://doi.org/10.1056/nejm199205143262003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002597029
    234 rdf:type schema:CreativeWork
    235 https://doi.org/10.1074/jbc.271.38.23222 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028514054
    236 rdf:type schema:CreativeWork
    237 https://doi.org/10.1111/j.1432-1033.1993.tb17986.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1045335243
    238 rdf:type schema:CreativeWork
    239 https://doi.org/10.1128/mcb.7.8.2745 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009211257
    240 rdf:type schema:CreativeWork
    241 https://doi.org/10.1172/jci116186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051772692
    242 rdf:type schema:CreativeWork
    243 https://doi.org/10.1210/endo.136.8.7628397 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064280347
    244 rdf:type schema:CreativeWork
    245 https://doi.org/10.1210/jcem.80.3.7883856 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064319418
    246 rdf:type schema:CreativeWork
    247 https://doi.org/10.1515/bchm3.1991.372.1.313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043420739
    248 rdf:type schema:CreativeWork
    249 https://doi.org/10.2337/diab.38.3.338 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070735825
    250 rdf:type schema:CreativeWork
    251 https://doi.org/10.2337/diab.40.11.1488 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070736378
    252 rdf:type schema:CreativeWork
    253 https://doi.org/10.2337/diab.42.11.1678 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025259697
    254 rdf:type schema:CreativeWork
    255 https://doi.org/10.2337/diab.42.9.1219 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070737139
    256 rdf:type schema:CreativeWork
    257 https://doi.org/10.2337/diab.44.9.1126 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070737650
    258 rdf:type schema:CreativeWork
    259 https://doi.org/10.2337/diab.45.11.1524 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070737725
    260 rdf:type schema:CreativeWork
    261 https://doi.org/10.2337/diacare.15.2.270 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070745632
    262 rdf:type schema:CreativeWork
    263 https://doi.org/10.2337/diacare.17.9.1039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070746463
    264 rdf:type schema:CreativeWork
    265 https://doi.org/10.2337/diacare.19.11.1200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070746952
    266 rdf:type schema:CreativeWork
    267 https://doi.org/10.2337/diacare.19.8.843 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070747210
    268 rdf:type schema:CreativeWork
    269 https://www.grid.ac/institutes/grid.425956.9 schema:alternateName Novo Nordisk (Denmark)
    270 schema:name Novo Nordisk A/S, Måløv, Denmark, DK
    271 rdf:type schema:Organization
    272 https://www.grid.ac/institutes/grid.5254.6 schema:alternateName University of Copenhagen
    273 schema:name Department of Medical Physiology, The Panum Institute, University of Copenhagen, Denmark, DK
    274 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...